Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lifecore Biomedical, Inc. - Common Stock (NQ: LFCR ) 7.490 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 119 Open 7.490 Bid (Size) 6.800 (50) Ask (Size) 7.700 (4) Prev. Close 7.490 Today's Range 7.490 - 7.490 52wk Range 3.679 - 8.900 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025 December 19, 2024 Webcast Scheduled for Thursday, January 2 at 4:30 p.m. Eastern From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment December 19, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Performance YTD +17.40% +17.40% 1 Month +0.67% +0.67% 3 Month +58.69% +58.69% 6 Month +45.72% +45.72% 1 Year +19.46% +19.46% More News Read More Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO November 26, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical Hosts Virtual Investor Day November 21, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical to Present at Stephens Annual Investment Conference November 12, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024 November 07, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations November 04, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update October 04, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock October 04, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Apogee Enterprises, Smart Sand And 3 Stocks To Watch Heading Into Friday October 04, 2024 Via Benzinga Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024 October 03, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology October 01, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm September 27, 2024 From The Schall Law Firm Via Business Wire The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR) September 26, 2024 From The Law Offices of Frank R. Cruz Via Business Wire SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore September 25, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events September 25, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire LFCR FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCR September 23, 2024 From The Rosen Law Firm PA Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm September 22, 2024 From Bragar Eagel & Squire Via GlobeNewswire DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore September 19, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational September 19, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm September 18, 2024 From Bragar Eagel & Squire Via GlobeNewswire LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline September 16, 2024 From Bernstein Liebhard LLP Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm September 14, 2024 From Bragar Eagel & Squire Via GlobeNewswire Faruqi & Faruqi Reminds Lifecore Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 27, 2024 - LFCR September 13, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference September 12, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
